氟膦酸酯和三甲氨蝶呤的剂量指南。

Formulary Pub Date : 1995-06-01

J M Wooten, K Chase, M C O'Connor, R B Henry

{"title":"氟膦酸酯和三甲氨蝶呤的剂量指南。","authors":"J M Wooten, K Chase, M C O'Connor, R B Henry","doi":"","DOIUrl":null,"url":null,"abstract":"The P & T Committee at Trinity Lutheran Hospital, a 320-bed, community/teaching hospital in Kansas City, MO, has developed dosing and monitoring guidelines for foscarnet sodium (Foscavir) and trimetrexate glucuronate (Neutrexin)--two drugs used to treat patients with opportunistic infections associated with the human immunodeficiency virus (HIV). Presented in this Experience Brief is a short discussion of these drugs, the rationale for guideline development, and the actual dosing and monitoring protocols devised.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"30 6","pages":"349-52"},"PeriodicalIF":0.0000,"publicationDate":"1995-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dosing guidelines for foscarnet and trimetrexate.\",\"authors\":\"J M Wooten, K Chase, M C O'Connor, R B Henry\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The P & T Committee at Trinity Lutheran Hospital, a 320-bed, community/teaching hospital in Kansas City, MO, has developed dosing and monitoring guidelines for foscarnet sodium (Foscavir) and trimetrexate glucuronate (Neutrexin)--two drugs used to treat patients with opportunistic infections associated with the human immunodeficiency virus (HIV). Presented in this Experience Brief is a short discussion of these drugs, the rationale for guideline development, and the actual dosing and monitoring protocols devised.\",\"PeriodicalId\":12354,\"journal\":{\"name\":\"Formulary\",\"volume\":\"30 6\",\"pages\":\"349-52\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Formulary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Formulary","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

位于密苏里州堪萨斯城的三一路德医院(Trinity Lutheran Hospital)是一家拥有320个床位的社区/教学医院，该医院的医药委员会已经制定了Foscavir钠(Foscavir)和trimetrexate glucuronate (Neutrexin)的剂量和监测指南，这两种药物用于治疗与人类免疫缺陷病毒(HIV)相关的机会性感染患者。本文简要介绍了这些药物、指南制定的基本原理以及实际给药和制定的监测方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Dosing guidelines for foscarnet and trimetrexate.

The P & T Committee at Trinity Lutheran Hospital, a 320-bed, community/teaching hospital in Kansas City, MO, has developed dosing and monitoring guidelines for foscarnet sodium (Foscavir) and trimetrexate glucuronate (Neutrexin)--two drugs used to treat patients with opportunistic infections associated with the human immunodeficiency virus (HIV). Presented in this Experience Brief is a short discussion of these drugs, the rationale for guideline development, and the actual dosing and monitoring protocols devised.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊